Inventor · disambiguated record
Haiyan Jiang
Also filed as: JIANG HAIYAN
32 granted patents·32 pending applications·256 citations·filing 2008–2025
97Inventor score
Files withBIOVERATIV THERAPEUTICS INC36BAYER HEALTHCARE LLC5AMUNIX OPERATING INC3BIOGEN HEMOPHILIA INC3BIOGEN IDEC INC2
Top patents by PatentIndex Score
64 records- 0198US9867873B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2015·Granted Jan 16, 2018·17 cites·25 claims
- 0298US9675676B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Jun 13, 2017·19 cites·30 claims
- 0398US9629903B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Apr 25, 2017·17 cites·29 claims
- 0498US9623091B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Apr 18, 2017·16 cites·28 claims
- 0597US10898554B1Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2020·Granted Jan 26, 2021·6 cites·22 claims
- 0696US10568943B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Feb 25, 2020·6 cites·18 claims
- 0796US9233145B2Factor IX polypeptides and methods of use thereofBIOGEN HEMOPHILIA INC·Filed 2013·Granted Jan 12, 2016·27 cites·22 claims
- 0895US10548954B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Feb 4, 2020·5 cites·16 claims
- 0994US11266720B2Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·6 cites·64 claims
- 1094US9670475B2Factor IX polypeptides and methods of use thereofPIERCE GLENN·Filed 2011·Granted Jun 6, 2017·18 cites·34 claims
- 1193US11091534B2Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Aug 17, 2021·8 cites·20 claims
- 1293US10881742B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Jan 5, 2021·5 cites·26 claims
- 1393US10561714B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Feb 18, 2020·3 cites·20 claims
- 1493US9050318B2Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereofDUMONT JENNIFER A·Filed 2010·Granted Jun 9, 2015·28 cites·31 claims
- 1591US10421798B2Factor VIII compositions and methods of making and using sameSCHELLENBERGER VOLKER·Filed 2012·Granted Sep 24, 2019·16 cites·44 claims
- 1690US11286528B2Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapyBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Mar 29, 2022·4 cites·14 claims
- 1790US9770757B2Method of making sound interface in overcast bimetal componentsGM GLOBAL TECH OPERATIONS LLC·Filed 2015·Granted Sep 26, 2017·2 cites·18 claims
- 1890US9241978B2Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereofBIOGEN HEMOPHILIA INC·Filed 2013·Granted Jan 26, 2016·15 cites·21 claims
- 1989US10548953B2Factor VIII-XTEN fusions and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted Feb 4, 2020·6 cites·17 claims
- 2088US12186375B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·1 cites·19 claims
- 2188US11370827B2Chimeric factor VIII polypeptides and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Jun 28, 2022·5 cites·48 claims
- 2288US11225650B2Methods of using FIX polypeptidesBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Jan 18, 2022·5 cites·20 claims
- 2386US2025195620A1Factor viii chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2484US10010622B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofDUMONT JENNIFER A·Filed 2012·Granted Jul 3, 2018·7 cites·22 claims
- 2582US10221455B2Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapyBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Mar 5, 2019·5 cites·25 claims
- 2682US2024212861A1Population pharmacokinetics tools and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2780US10391152B2Methods of using a fixed dose of a clotting factorBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Aug 27, 2019·5 cites·14 claims
- 2877US2022265780A1Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2975US12371747B2Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapyBIOVERATIV THERAPEUTICS INC·Filed 2022·Granted Jul 29, 2025·0 cites·17 claims
- 3075US2023322900A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3175US2023019286A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3274US2021008178A1Factor ix polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3373US2018207244A1Factor IX Polypeptides and Methods of Use ThereofBIOVERATIV THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3470US9422362B2Targeted coagulation factors and method of using the sameBAYER HEALTHCARE LLC·Filed 2014·Granted Aug 23, 2016·0 cites·15 claims
- 3570US2022064622A1Methods of using fix polypeptidesBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3670US2022056108A1Factor viii complex with xten and von willebrand factor protein, and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3769US2019315835A1Factor viii compositions and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3868US10656167B2Assays to monitor bleeding disordersSOMMER JURG·Filed 2012·Granted May 19, 2020·2 cites·13 claims
- 3968US2023011438A1Chimeric factor viii polypeptides and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4067US11747351B2Assays to monitor bleeding disordersBIOVERATIV THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·0 cites·15 claims
- 4167US2015038421A1Factor viii compositions and methods of making and using sameAMUNIX OPERATING INC·Filed 2014·Application pending·0 cites
- 4265US10325687B2Population pharmacokinetics tools and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted Jun 18, 2019·2 cites·23 claims
- 4364US2016376344A1Factor viii compositions and methods of making and using sameAMUNIX OPERATING INC·Filed 2016·Application pending·0 cites
- 4464US2011077202A1Targeted Coagulation Factors and Method of Using the SameBAYER HEALTHCARE LLC·Filed 2009·Application pending·0 cites
- 4563US10035840B2Targeted coagulation factors and method of using the sameBAYER HEALTHCARE LLC·Filed 2016·Granted Jul 31, 2018·0 cites·15 claims
- 4663US2012027743A1Method for the Treatment of HemophiliaJIANG HAIYAN·Filed 2009·Application pending·0 cites
- 4762US2012269817A1Monoclonal Antibodies Against Tissue Factor Pathway InhibitorWANG ZHUOZHI·Filed 2009·Application pending·0 cites
- 4860US2013017997A1Factor VIII Compositions and Methods of Making and Using SameAMUNIX OPERATING INC·Filed 2012·Application pending·0 cites
- 4959US2020318140A1Methods and compositions for increasing rna activity in a cellBIOVERATIV THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5059US2024200845A1Ice makerJIUJIA REFRIGERATION LUAN CO LTD·Filed 2024·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Haiyan Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →